Get started Log in

ALGEN — genOway SA Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
€26.61m
Enterprise Value
€38.53m
Revenue
€20.96m

Brief: Genoway FY EBITDA Up At EUR 1 Mln
30/03/2021 16:55
Brief: Genoway Announces Issuance Of First European Patent For Smash Technology
26/01/2021 17:11
Brief: Genoway Sees Revenue Of 30 Million Euros By 2024
19/01/2021 17:05
Brief: genOway Gets EUR 2.3 Mln Subvention For ICP Models
05/01/2021 16:52
Brief: Genoway H1 EBITDA Loss Narrows To 0.2 Million Euros
17/09/2020 16:52
Brief: Genoway ‍H1 Revenue Up At 4.8 Million Euros
16/07/2020 16:45
Brief: Genoway Says Merck Gets First Two Patents For CRISPR/Cas9 Techonology In The U.S
19/05/2020 17:08
Brief: Genoway FY EBITDA Down At 0.5 Million Euros
26/03/2020 17:00
Brief: Genoway: Issuance Of 1St American Patent For Smash Technology
24/02/2020 17:47
Brief: Genoway Raises 6.2 Million Euros
28/01/2020 06:48
Brief: Genoway FY Revenue Down At 9.5 Million Euros
15/01/2020 17:06
Brief: Genoway Signs Distribution Contract In Asia
13/01/2020 17:30
Brief: GenOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance
07/01/2020 09:19
Brief: Genoway H1 2019 EBITDA Profit Turns To 0.4 Million Euros Loss
23/09/2019 17:39
Brief: Genoway Nominates Christian Grenier As Chairman And CEO
27/05/2019 17:39
Brief: Genoway FY Net Result Down At 0.6 Million Euros
28/03/2019 18:10
Brief: Genoway FY Revenue Up At 10.8 Million Euros
21/01/2019 17:18
Brief: MilliporeSigma And genOway Form CRISPR/Cas9 Alliance To Develop Rodent Models
10/12/2018 16:35
Brief: Genoway H1 Net Profit Down At ‍0.3 Million Euros
10/09/2018 17:00
Brief: Genoway Acquires Axenis
04/09/2018 18:11